Form 8-K - Current report:
SEC Accession No. 0000353569-22-000011
Filing Date
2022-02-04
Accepted
2022-02-04 17:14:51
Documents
17
Period of Report
2022-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20220131.htm   iXBRL 8-K 52589
2 EX-10.1 a02x04x2022ex1012022cashin.htm EX-10.1 9161
3 EX-10.2 a02x04x2022ex1022022annual.htm EX-10.2 11726
4 EX-10.3 a02x04x2022ex103formofsucc.htm EX-10.3 3612
5 EX-10.4 a02x04x2022ex104formofinte.htm EX-10.4 7090
  Complete submission text file 0000353569-22-000011.txt   263253

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20220131.xsd EX-101.SCH 2247
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20220131_def.xml EX-101.DEF 14507
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20220131_lab.xml EX-101.LAB 28042
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20220131_pre.xml EX-101.PRE 15006
11 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20220131_htm.xml XML 10699
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 22594563
SIC: 2835 In Vitro & In Vivo Diagnostic Substances